$180.06
0.000.00%
Pre-Market: 4:00 PM EDT
Krystal Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Krystal Biotech using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-19 | $1.52 | $1.29 | 17.8 % |
Q3 | 2024-11-04 | $0.91 | $0.90 | 1.11 % |
Q2 | 2024-08-05 | $0.94 | $0.62 | 51.6 % |
Q1 | 2024-05-06 | $0.46 | $0.15 | 206.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-19 | $91.14M | $96.95M | -5.99 % |
Q3 | 2024-11-04 | $83.84M | $82.94M | 1.09 % |
Q2 | 2024-08-05 | $70.28M | $64.43M | 9.09 % |
Q1 | 2024-05-06 | $45.25M | $47.42M | -4.58 % |
Krystal Biotech (KRYS) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 19, 2025 for Q4.
The Actual EPS was $1.52, which beat the estimate of $1.29.
The Actual Revenue was $91.1M, which missed the estimate of $97M.
Browse earnings estimates, EPS, and revenue on all stocks.